07.24.2018 Issue 411

   
Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR: Latest Headlines in HEOR:

HealthEconomics.Com, Scientist.Com
Partner on RWE/HEOR Initiative

Wednesday, July 11

HealthEconomics.Com and Scientist.Com are partnering to connect real-world evidence researchers with service providers in a bid to facilitate research sourcing, trim costs and bolster market access.

Article: Value-Based Models Offer Near- and Long-Term Opportunities

Merck Avoids Lowering Cost of Blockbuster Products

Is Trump’s Fight Against Drug Prices Gaining Steam?

Novartis CEO Announces Freeze on Price Hikes

GHG's Gorman Talks Medicare Star Ratings, Value

Engelberg: Taxpayers Deserve Reasonable Drug Prices for Federally-Funded Drug Development

Report Spotlights ICER Analysis on Vertex’s CF Drugs

ICER Releases Report on Inotersen, Patisiran

MHE: Top 10 Value-Based Care Updates


Chief Scientific Officer

Director Global Outcomes Research

Associate Health Economist

Health Economist

Associate Systematic Reviewer

Systematic Reviewer

Lead Health Economist

Senior Systematic Reviewer

Industry Spotlight



Conferences Webinars
6th National Physician Advisor and Utilization Review Boot Camp
    July 25-27, Los Angeles, California

14th Annual Publication Planning
    August 15-16, Philadelphia, Pennsylvania

6th Annual Reimbursement and Access
    August 15-16, Philadelphia, Pennsylvania

World Congress on Biosensors and Bioelectronics
    August 20-21, Chicago, Illinois

P4AD Webinar Series, Part 3: Persuading Elected Officials + Press
    July 25

Industry Perceptions and Expectations: The Role of ICER as an Independent HTA
    July 31


Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
HTA in Europe: Key Success Factors for Positive HTA Recommendations

Paying for Digital Health: Payer Insights

Benchmarking Pharma’s MSL Capabilities

Biosimilars: U.S. Payer Perspectives

KAM Metrics: Driving Efficiency, Measuring Success

Biosimilars: E.U. Payer Perspectives

Impact of Displaying in-EHR Patient Drug Prices With or Without Patient Savings Messages

Taking a Total View: Linking Pharmacy + Medical Drug Trends

Reinventing Claims Payment for a Value-Based World

Payers that Engage Members See Better Health Outcomes, Savvier Spending

Seeing the Value and Transparency of Medicare Part B


Special Thanks to Our Partners:
   Evidera    G&J Lee RecruitmentHealthCoreMAPSUniversity of FL
              Truven    XcendaOM1Parexel   Jefferson
      Dymaxium        Precision Xtract    Pharmerit    eMax Health
SciformixEvidence PartnersICON